Phytotherapy of BPH with Cernilton ® - Results of a Controlled Prospective
Study
H. Becker, L. Ebeling
Topic
The efficacy and benefit to risk ratio of Cernilton ® in the treatment of
patients with BPH are documented in a controlled prospective study and the
resulting consequences for long-term treatment are discussed.
Introduction
Among the various treatment options for benign prostatic hyperplasia (BPH),
phytotherapy is established and recognized as a treatment alternative directed
at the symptoms because of its high benefit to risk ratio. Follow-up examination
during therapy allows physicians to monitor treatment response and to confirm
the appropriateness of conservative therapy or revise the treatment strategy. In
view of recent epidemiological studies documenting relatively rare indications
for surgical treatment and the critical re-evaluation of TURP phytotherapy is a
preferred treatment option in the initial stages of BPH. Read
the Full Study